Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Vesigen | ARRDC1 Mediated Microvesicles (ARMMs) | Intracellular |
Description | Expanding the universe of druggable Vesigen’s patented technology uses ARRDC1 Mediated Microvesicles (ARMMs) to deliver intracellular therapeutics to previously undruggable |
Keywords | N/A |
WebSite | vesigentx.com |
Host IP | 50.87.225.217 |
Location | United States |
Site | Rank |
US$4,377,407
Last updated: 2023-05-01 02:33:16
vesigentx.com has Semrush global rank of 2,417,939. vesigentx.com has an estimated worth of US$ 4,377,407, based on its estimated Ads revenue. vesigentx.com receives approximately 505,086 unique visitors each day. Its web server is located in United States, with IP address 50.87.225.217. According to SiteAdvisor, vesigentx.com is safe to visit. |
Purchase/Sale Value | US$4,377,407 |
Daily Ads Revenue | US$4,041 |
Monthly Ads Revenue | US$121,221 |
Yearly Ads Revenue | US$1,454,647 |
Daily Unique Visitors | 33,673 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
vesigentx.com. | A | 7199 | IP: 50.87.225.217 |
vesigentx.com. | NS | 86400 | NS Record: ns2.p30.dynect.net. |
vesigentx.com. | NS | 86400 | NS Record: ns4.p30.dynect.net. |
vesigentx.com. | NS | 86400 | NS Record: ns3.p30.dynect.net. |
vesigentx.com. | NS | 86400 | NS Record: ns1.p30.dynect.net. |
vesigentx.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-1.mimecast.com. |
vesigentx.com. | MX | 3600 | MX Record: 10 us-smtp-inbound-2.mimecast.com. |
vesigentx.com. | TXT | 3600 | TXT Record: v=spf1 include:us._netblocks.mimecast.com ~all |
vesigentx.com. | TXT | 3600 | TXT Record: 0ed1fe018a8328b23339984c839f607c0e0562ce42 |
LinkedIn Twitter About Company Overview Team Investors Our Science Programs News Careers Contact Menu Menu About Company Overview Team Investors Our Science Programs News Careers Contact Expanding the universe of druggable targets Novel Therapeutics Enabled by Engineering ARRDC1-Mediated Microvesicles Novel technology, new treatment opportunities Vesigen’s patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), can be used to precisely deliver a wide range of payloads, including gene editing complexes, proteins, and RNAs to a unique set of tissue and cell types. Vesigen has demonstrated highly efficient in vitro and in vivo functional delivery of payloads across multiple cell types and is committed to developing transformative medicines that address current unmet needs. Learn more about us Repurposing inter-tissue communication to develop new therapies ARMMs are a natural communication system used by cells to transfer signals. Vesigen has developed approaches to engineer |
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 18:09:35 GMT Server: Apache X-Redirect-By: WordPress Upgrade: h2,h2c Connection: Upgrade Location: https://www.vesigentx.com/ host-header: d3AuYmx1ZWhvc3QuY29t Content-Type: text/html; charset=UTF-8 HTTP/2 200 vary: User-Agent,Accept-Encoding last-modified: Tue, 28 Sep 2021 18:44:28 GMT accept-ranges: bytes content-length: 47259 host-header: d3AuYmx1ZWhvc3QuY29t cache-control: max-age=0, no-cache, no-store, must-revalidate pragma: no-cache expires: Mon, 29 Oct 1923 20:30:00 GMT content-type: text/html; charset=UTF-8 date: Sat, 23 Oct 2021 18:09:36 GMT server: Apache |
Domain Name: VESIGENTX.COM Registry Domain ID: 2483220681_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2020-12-22T07:45:34Z Creation Date: 2020-01-21T21:08:37Z Registry Expiry Date: 2022-01-21T21:08:37Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.P30.DYNECT.NET Name Server: NS2.P30.DYNECT.NET Name Server: NS3.P30.DYNECT.NE Name Server: NS4.P30.DYNECT.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T04:09:18Z <<< |